Joshua Jennings
Stock Analyst at TD Cowen
(3.73)
# 843
Out of 4,667 analysts
64
Total ratings
50%
Success rate
8.71%
Average return
Main Sectors:
Stocks Rated by Joshua Jennings
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Maintains: Buy | $175 → $120 | $77.20 | +55.44% | 9 | Nov 18, 2024 | |
| CBLL CeriBell | Initiates: Buy | $31 | $25.06 | +23.70% | 1 | Nov 5, 2024 | |
| BSX Boston Scientific | Maintains: Buy | $86 → $100 | $90.17 | +10.90% | 6 | Oct 21, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $10 | $4.41 | +126.76% | 2 | Oct 18, 2024 | |
| ALUR Allurion Technologies | Initiates: Buy | $2 | $0.46 | +336.87% | 1 | Oct 2, 2024 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $75 → $99 | $92.70 | +6.80% | 3 | Sep 16, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Hold | $143 → $119 | $109.27 | +8.90% | 1 | Sep 6, 2024 | |
| VCEL Vericel | Maintains: Buy | $55 → $60 | $57.26 | +4.79% | 2 | Aug 27, 2024 | |
| AIG American International Group | Maintains: Hold | $83 → $80 | $74.66 | +7.15% | 1 | Aug 13, 2024 | |
| OM Outset Medical | Maintains: Buy | $9 → $3 | $0.73 | +313.39% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $100 → $70 | $69.54 | +0.66% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $185 | $153.11 | +20.83% | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $40 | $32.63 | +22.59% | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $365 → $400 | $385.68 | +3.71% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $60 | $41.81 | +43.51% | 4 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $34 | $30.15 | +12.77% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $14 → $18 | $7.69 | +134.07% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $114 → $125 | $75.24 | +66.14% | 1 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $6 → $25 | $16.78 | +48.99% | 1 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $130 | $115.93 | +12.14% | 9 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $5 | $2.03 | +146.31% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $117 | $84.11 | +39.10% | 3 | May 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $450 | $9.03 | +4,883.39% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $12 | $9.93 | +20.85% | 1 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $306 → $275 | $222.39 | +23.66% | 1 | Feb 7, 2020 |
TransMedics Group
Nov 18, 2024
Maintains: Buy
Price Target: $175 → $120
Current: $77.20
Upside: +55.44%
CeriBell
Nov 5, 2024
Initiates: Buy
Price Target: $31
Current: $25.06
Upside: +23.70%
Boston Scientific
Oct 21, 2024
Maintains: Buy
Price Target: $86 → $100
Current: $90.17
Upside: +10.90%
Humacyte
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $4.41
Upside: +126.76%
Allurion Technologies
Oct 2, 2024
Initiates: Buy
Price Target: $2
Current: $0.46
Upside: +336.87%
PROCEPT BioRobotics
Sep 16, 2024
Maintains: Buy
Price Target: $75 → $99
Current: $92.70
Upside: +6.80%
Zimmer Biomet Holdings
Sep 6, 2024
Maintains: Hold
Price Target: $143 → $119
Current: $109.27
Upside: +8.90%
Vericel
Aug 27, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $57.26
Upside: +4.79%
American International Group
Aug 13, 2024
Maintains: Hold
Price Target: $83 → $80
Current: $74.66
Upside: +7.15%
Outset Medical
Aug 8, 2024
Maintains: Buy
Price Target: $9 → $3
Current: $0.73
Upside: +313.39%
Jul 25, 2024
Downgrades: Hold
Price Target: $100 → $70
Current: $69.54
Upside: +0.66%
Jul 18, 2024
Maintains: Buy
Price Target: $195 → $185
Current: $153.11
Upside: +20.83%
May 10, 2024
Downgrades: Hold
Price Target: $40
Current: $32.63
Upside: +22.59%
Apr 11, 2024
Maintains: Buy
Price Target: $365 → $400
Current: $385.68
Upside: +3.71%
Mar 12, 2024
Maintains: Outperform
Price Target: $50 → $60
Current: $41.81
Upside: +43.51%
Aug 4, 2023
Maintains: Outperform
Price Target: $52 → $34
Current: $30.15
Upside: +12.77%
May 11, 2023
Maintains: Outperform
Price Target: $14 → $18
Current: $7.69
Upside: +134.07%
Feb 10, 2023
Maintains: Outperform
Price Target: $114 → $125
Current: $75.24
Upside: +66.14%
Dec 30, 2022
Maintains: Outperform
Price Target: $6 → $25
Current: $16.78
Upside: +48.99%
Dec 13, 2022
Maintains: Outperform
Price Target: $130
Current: $115.93
Upside: +12.14%
Nov 11, 2022
Maintains: Outperform
Price Target: $7 → $5
Current: $2.03
Upside: +146.31%
May 27, 2022
Maintains: Outperform
Price Target: $125 → $117
Current: $84.11
Upside: +39.10%
Dec 7, 2021
Initiates: Outperform
Price Target: $450
Current: $9.03
Upside: +4,883.39%
Sep 3, 2020
Initiates: Outperform
Price Target: $12
Current: $9.93
Upside: +20.85%
Feb 7, 2020
Downgrades: Market Perform
Price Target: $306 → $275
Current: $222.39
Upside: +23.66%